Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LATISSE vs LEFLUNOMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LATISSE vs LEFLUNOMIDE: Safety Overview

Metric LATISSE LEFLUNOMIDE
Total FAERS Reports 980 56,539
Deaths Reported 0 5,283
Death Rate N/A 9.3%
Hospitalizations 0 13,923
Average Patient Age 53.0 yrs 51.3 yrs
% Female Patients N/A 87.3%
FDA Approval Date N/A Apr 24, 2019
Manufacturer N/A Alembic Pharmaceuticals Inc.
Route N/A ORAL
Marketing Status N/A Prescription